ZTS

Stock Details

ZTS is Zoetis Inc.'s stock. Stock exchange NYSE (Currency USD). Average price in 50 days is 163.90$. Average daily volumn in 3 months 1.68M. Market cap 72.37B

Stock symbol : ZTS. Exchange : NYSE. Currency : USD
Lastest price : 154.59$. Total volume : 1.21M. Market state POST
Click reload if you want to check the lastest price on market!!!

Zoetis Inc. (ZTS)

Last Price

154.59$

Change

-0.16

Volume

1.21M


Previous Close	154.75
Open	152.74
Day Range	152.00-155.63
Bid	151.74 x 1.2k
Ask	155.24 x 800
Volume	1.21M
Average Volume	1.68M


Market Cap	72.37B
Beta	0.76
52 Week Range	147.77-249.27
Trailing P/E	35.05
Foward P/E	27.56
Dividend (Yield %)	0.84%
Ex-Dividend Date	2022-07-20

Financial Details

According to Zoetis Inc.'s financial reports the company's revenue in 2021 were 7.78B an increase( +16.67%) over the years 2020 revenue that were of 6.67B. In 2021 the company's total earnings were 2.04B while total earnings in 2020 were 1.64B( +100%).

Loading ...

Organization

Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. The company also offers vaccines, which are biological preparations to prevent diseases of the respiratory, gastrointestinal, and reproductive tracts or ... induce a specific immune response; anti-infectives that prevent, kill, or slow the growth of bacteria, fungi, or protozoa; and parasiticides that prevent or eliminate external and internal parasites, which include fleas, ticks, and worms. It also provides other pharmaceutical products that comprise pain and sedation, antiemetic, reproductive, and oncology products; dermatology products for itch associated with allergic conditions and atopic dermatitis; and medicated feed additives, which offer medicines to livestock. In addition, the company provides portable blood and urine analysis testing, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, including nutritionals and agribusiness services, as well as products and services in areas, such as biodevices, genetics tests, and precision animal health. It markets its products to veterinarians, livestock producers, and retail outlets, as well as third-party veterinary distributors through its sales representatives, and technical and veterinary operations specialists. The company was founded in 1952 and is headquartered in Parsippany, New Jersey.

Market Cap:

72.37B

Revenue:

7.78B

Total Assets:

13.9B

Total Cash:

3.48B

News about "Zoetis Inc."

Zoetis Inc.: Discounted price offers buying opportunity

Source from : YAHOO!Finance - 8 month ago

Find the latest Zoetis Inc. (ZTS) stock forecast based on top analyst's estimates, plus more investing and trading data from Yahoo Finance ...See details»

FY2023 EPS Estimates for Zoetis Inc. (NYSE:ZTS) Boosted by Cantor Fitzgerald

Source from : Defense World - 2 days ago

Equities researchers at Cantor Fitzgerald boosted their FY2023 earnings estimates for Zoetis in a report released on Friday, September 30th. Cantor Fitzgerald analyst L. Chen now expects that the ...See details»

Zoetis Inc. (NYSE:ZTS) Shares Acquired by Sawtooth Solutions LLC

Source from : Defense World - 5 days ago

Sawtooth Solutions LLC raised its position in shares of Zoetis Inc. (NYSE:ZTS – Get Rating) by 15.5% in the second quarter, according to its most recent Form 13F filing with the Securities and ...See details»

Zoetis Announces the Completion of its Acquisition of Jurox, a Leading Provider of Livestock and Companion Animal Products

Source from : Yahoo Finance - 5 days ago

2022--(BUSINESS WIRE)--Zoetis Inc. (NYSE: ZTS) today announced it has completed the acquisition of Jurox, a privately held animal health company that develops, manufactures and markets a wide ...See details»

The Price Is Right For Zoetis Inc. (NYSE:ZTS)

Source from : Yahoo - 11 days ago

When close to half the companies in the United States have price-to-earnings ratios (or "P/E's") below 13x, you may consider Zoetis Inc. (NYSE:ZTS) as a stock to avoid entirely with its 33.6x P/E ...See details»

Zoetis to Host Webcast and Conference Call on Third Quarter 2022 Financial Results

Source from : Daily Herald - 6 days ago

Investors and the public may access the live webcast by visiting the Zoetis website at Information on accessing and pre-registering for the webcast is available beginning today. A replay of the ...See details»

$95M Zoetis animal health products facility gets tax break from city of Kalamazoo

Source from : MLive - 2 days ago

The Kalamazoo City Commission approved a tax break for a new $95-million animal health products manufacturing facility.See details»

Oversold Conditions For Zoetis (ZTS)

Source from : Nasdaq - 13 days ago

A stock is considered to be oversold if the RSI reading falls below 30. In trading on Thursday, shares of Zoetis Inc (Symbol: ZTS) entered into oversold territory, hitting an RSI reading of 29.8 ...See details»

Insiders at Zoetis Inc. (NYSE:ZTS) sold US$4.0m worth of stock, possibly indicating weakness in the future

Source from : Yahoo Finance - 3 days ago

Many Zoetis Inc. (NYSE:ZTS) insiders ditched their stock over the past year, which may be of interest to the company's shareholders. When evaluating insider transactions, knowing whether insiders are ...See details»

Johne’s Disease Diagnostics Market Demand, Future Prospects and Forecasts to 2028 | IDEXX Laboratories, IDVET, VMRD Inc., Biomeriux SA

Source from : MarketWatch - 5 days ago

Global Johne’s Disease Diagnostics market report provides thorough information about the current state of the industry. It relies on primary & secondary research, as well as private databases & paid ...See details»

Zoetis Announces the Completion of its Acquisition of Jurox, a Leading Provider of Livestock and Companion Animal Products

Source from : Joplin Globe - 5 days ago

Zoetis Inc. (NYSE: ZTS) today announced it has completed the acquisition of Jurox, a privately held animal health company that develops, manufactures and markets a wide range of veterinary ...See details»

Zoetis to Host Webcast and Conference Call on Third Quarter 2022 Financial Results

Source from : Joplin Globe - 6 days ago

Zoetis Inc. (NYSE:ZTS) will host a webcast and conference call at 8:30 a.m. (ET) on Thursday, Nov. 3, 2022. Chief Executive Officer Kristin Peck and Executive Vice President and Chief Financial ...See details»